PS

Priyanka Sandip Sanap

Active Director Director DIN 09061528
DIN 09061528 First appointment Feb 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Priyanka Sandip Sanap

Data last updated:

Priyanka Sandip Sanap is a Director at Amnour Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Amnour Pharmaceuticals Private Limited reported revenue of ₹68.7 Lakh (FY 2025).

DIN 09061528
Primary Designation Director
Industry Pharma
First Appointment 10 Feb 2021
Oldest Company Age 5 yrs
Largest company Amnour Pharmaceuticals Private Limited · ₹68.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Feb 20212021₹68.7 Lakh (FY 2025)Active

Board colleagues of Priyanka Sandip Sanap

Directorship timeline

Open interactive timeline →
Amnour Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priyanka Sandip Sanap

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Sandip Sanap

Priyanka Sandip Sanap currently holds 1 directorship: Amnour Pharmaceuticals Private Limited (Director, since 10 Feb 2021, revenue ₹68.7 Lakh (FY 2025)).

Priyanka Sandip Sanap was first appointed on 10 Feb 2021 as Director at Amnour Pharmaceuticals Private Limited.

The current boards of Priyanka Sandip Sanap's companies include Shweta Dattatray Kusmude (Amnour Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available